"HEK293 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5.
| Descriptor ID |
D057809
|
| MeSH Number(s) |
A11.251.210.172.750 A11.436.334
|
| Concept/Terms |
HEK293 Cells- HEK293 Cells
- Cell, HEK293
- Cells, HEK293
- HEK293 Cell
- 293T Cells
- 293T Cell
- Cell, 293T
- Cells, 293T
- HEK 293 Cells
- 293 Cell, HEK
- 293 Cells, HEK
- Cell, HEK 293
- Cells, HEK 293
- HEK 293 Cell
- Human Kidney Cell Line 293
- Human Embryonic Kidney Cell Line 293
- HEK 293 Cell Line
|
Below are MeSH descriptors whose meaning is more general than "HEK293 Cells".
Below are MeSH descriptors whose meaning is more specific than "HEK293 Cells".
This graph shows the total number of publications written about "HEK293 Cells" by people in this website by year, and whether "HEK293 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 9 | 9 |
| 2013 | 0 | 10 | 10 |
| 2014 | 0 | 18 | 18 |
| 2015 | 0 | 19 | 19 |
| 2016 | 0 | 17 | 17 |
| 2017 | 0 | 255 | 255 |
| 2018 | 0 | 249 | 249 |
| 2019 | 0 | 84 | 84 |
| 2020 | 0 | 102 | 102 |
| 2021 | 0 | 133 | 133 |
To return to the timeline, click here.
Below are the most recent publications written about "HEK293 Cells" by people in Profiles.
-
An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility. Bioengineered. 2021 12; 12(1):4407-4419.
-
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerg Microbes Infect. 2021 Dec; 10(1):1555-1573.
-
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
-
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. J Infect Dis. 2021 10 28; 224(8):1305-1315.
-
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. J Infect Dis. 2021 09 17; 224(6):989-994.
-
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants. J Virol. 2021 09 09; 95(19):e0068521.
-
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther. 2021 09 01; 6(1):331.
-
Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins. Acta Biochim Biophys Sin (Shanghai). 2021 Aug 31; 53(9):1134-1141.
-
SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol Basis Dis. 2021 12 01; 1867(12):166260.
-
Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines. STAR Protoc. 2021 12 17; 2(4):100818.